Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02934477 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

StatusRecruiting
PhaseNot specified
Started2016-11
View on ClinicalTrials.gov ↗

Amendment history

2023-08-29
2 amendments v6-v7
2 re-verifications since 2022-03-17, no change to tracked fields
2021-01-28
Study Status, Contacts/Locations v5
Study sitescontacts updated at 1 of 1 site
2020-01-21
Study Status v4
Re-verified, no change to tracked fields
2017-07-27
Study Status, Contacts/Locations v3
Study sitescontacts updated at 1 of 1 site
2017-03-10
Study Identification, Study Status v2
Study title+12 characters
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
2017-02-13
Not Yet Recruiting→Recruiting Study Identification, Study Status, Sponsor/Collaborators, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Study sites0→1
Lead sponsorMedical College of Wisconsin→Center for International Blood and Marrow Transplant Research
Collaborators4 to 3 entries
Center for International Blood and Marrow Transplant Research
2016-10-12
Original filing
This observational study will compare outcomes of a prospectively-enrolled cohort of Hematopoietic Stem Cell Transplant (HCT) recipients with outcomes of a cohort of age-matched historical non-HCT controls. Patients undergoing alloHCT will receive HCT in a US transplant center and be reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) using well-established CIBMTR report forms and data collection procedures as well as a study-specific supplemental form. Data on the historical non-HCT controls will be collected at 14 US academic centers. These centers will provide data on all consecutive patients with PMF, post-ET MF, or post-PV MF referred to their institutions between 2000 and 2012.
Trial Details
NCT Number NCT02934477
Lead Sponsor Center for International Blood and Marrow Transplant Research
Collaborators: National Marrow Donor Program, National Institutes of Health (NIH), National Cancer Institute (NCI)
Conditions Myelofibrosis
Enrollment 650 participants
Start Date 2016-11
Primary Completion 2026-11 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2023-08-30